The global vascular access devices market size was valued at USD 1.77 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 5% from 2023 to 2030. Despite the COVID-19 impact, it is anticipated that the vascular access device industry will have moderate growth throughout the forecast period. Patient demographics, such as the aging global population, the rising cancer prevalence, and the widespread metabolic, respiratory, and cardiovascular disorders will have a significant impact on market growth over the projection period. As a result, more patients are required to utilize a vascular access device while undergoing treatment.
Additionally, market segments including Short PIVCs, PICC, and CVCs are a key factor in the industry's growth. In particular, it is anticipated that sales of CVC devices would be overtaken by PICC sales over the forecast period, which will considerably hamper the CVC market growth to some extent. Furthermore, the market will also benefit from the use of costly power-injectable, safe, anti-thrombogenic, and antibacterial technologies that are designed to reduce complication rates.
The global COVID-19 pandemic has had a negative impact on the vascular access device market. Furthermore, despite a significant decline in vascular access device sales overall in 2020, the industry's revenues increased in the following years as a result of rising PICC, CVC, and dialysis catheter adoption due to an uptick in demand for vascular access devices used in the treatment and management of COVID-19 and related patients.
Furthermore, the market is supported by the awareness of the expenses associated with catheter-related complications in healthcare institutions, leading to the rising need for solutions that can lower problem rates. Numerous recent clinical investigations have shown that improper usage and upkeep of vascular access devices could be a significant part of the problems. Manufacturers could distinguish their products from those of their competitors for the end-user and foster brand loyalty by giving online or in-person training programs. The Teleflex Academy program from Teleflex Medical and the Clinical Training programs from BD are a few examples of such successful programs.
Numerous clinical trials being conducted on the available technologies are anticipated to have a favorable impact on the market. Clinical data confirming the safety and cost-efficiency of certain devices will significantly affect device purchase decisions because many vascular access devices perform similar functions and differ only slightly from each other. For instance, due to their proven advantages for end-user safety, short PIVCs and Huber needles with safety features such as BD's Nexiva, BD's HuberPlus, B. Smiths Medical's PROTECTIV, and Braun's Introcan Safety have been extensively accepted in healthcare institutions.
The market is also anticipated to prosper from increased rivalry driven by companies launching cutting-edge technologies in the coming year.
Access Vascular receives FDA approval for its HydroPICC PICC second generation
Bluegrass Vascular Technologies
Surfacer Inside-Out access catheter system
Surfacer Inside-Out access catheter system of Bluegrass Vascular Technologies receives FDA de novo clearance
Arrow ErgoPack catheter and PSI system
Teleflex reveals the availability of the Arrow ErgoPack catheter and PSI system
Evo IQ Syringe Infusion System
Baxter's Evo IQ Syringe Infusion System, a new component of the company's Evo IQ Infusion Platform, receives the CE mark
Based on the product type, the market is segmented into Short Peripheral Intravenous Catheters (Short PIVCs), Huber Needles, Midline Catheters, Peripherally Inserted Central Catheters (PICCs) Central Venous Catheters (CVCs), Dialysis Catheters, and Implantable Ports. In 2022, the short peripheral intravenous catheter segment held a dominating revenue share of more than 40%. In addition, the market for short PIVCs will hold a disproportionately large portion of the revenue during the forecast period, mostly due to consumers preferring more expensive and safer short PIVCs than common devices.
Moreover, altering usage patterns in recent years, particularly in nations like the U.S., as a result of the Michigan Appropriateness Guide to Intravenous Catheters (MAGIC) recommendations, have pushed vascular access specialists away from a historical access system, dramatically limiting the uptake of PICCs.
On the other hand, the CVC market is anticipated to hold the second leading position in the market. However, the usage of CVC is limited to some extent by strong pressure from competing devices such as PICCs and implantable ports.
Based on the end-use, the market is segmented into hospitals, ambulatory care centers, and other end-use (clinics, etc.).
With a revenue share of more than 50% in 2022, the hospital-based segment dominated the market. The substantial availability of highly skilled and experienced healthcare staff at hospitals will likely allow the industry to continue its dominance over the coming years. In healthcare facilities like dialysis clinics and hospitals, the presence of qualified and experienced staff offers the best possible care and improved vascular access outcomes. The category is expected to be driven by a number of reasons, including the increasing emphasis of companies on developing independent vascular access facilities.
North America dominated the market with the largest revenue share of over 58% in 2022. The region's market is expanding as a result of the existence of key players, a favorable reimbursement framework, and substantial government expenditure in the creation of cutting-edge medical devices. Other factors influencing market growth include rising healthcare costs, government efforts, and increasing disposable income.
Asia Pacific is expected to have accelerated growth during the forecast period. Additionally, it is anticipated that the market would be supported by the presence of local distributors with established local connections that have a competitive advantage in the vascular access device market. For instance, overseas rivals use alliances with regional distributors as a strategy to enlarge their operations in the Asia Pacific area. For example, according to a press release from Medical Specialties Australasia in June 2017, AngioDynamics has a deal with distribution organization Medical Specialties, which is the distributor of AngioDynamics' BioFlo and Xcela PICCs on the east coast of Australia, where more than 80% of the nation's population lives. This collaboration will increase AngioDynamics' PICC sales in Australia.
The key market players are focusing on the launch of innovative products, strategic acquisitions, and technological advancements that will allow companies to add complementary devices to their existing product lines. For instance, in July 2021, BD bought Velano Vascular; this acquisition would expand BD's vascular access portfolio and include the latter's cutting-edge needle-free blood-draw technology, which is said to lessen the agony of many needle sticks. In July 2018, BD also purchased TVA Medical, a company that creates vascular access devices for hemodialysis patients with chronic renal disease. These acquisitions have extended BD's range of complementary products and will assist the company to maintain its notable position in the vascular access device market.
The rising number of product approvals, participants, and effective distribution agreements are all factors that have led to the increased industry rivalry. As a result, it is anticipated that industry competition would be strong throughout the forecast period. Some of the prominent players in the global vascular access devices market include:
Smith’s Medical (ICU Medical, Inc)
Medical Components, Inc.
Terumo Medical Corporation
Access Vascular, Inc.
Market size value in 2023
USD 1.88 billion
Revenue forecast in 2030
USD 2.64 billion
CAGR of 5% from 2023 to 2030
Base year for estimation
Actual estimates/Historical data
2018 - 2021
2023 - 2030
Revenue in USD billion & CAGR from 2023 to 2030
Revenue forecast, company share, competitive landscape, growth factors, and trends
Product, end-use, region
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
U.S.; Canada; UK; France; Italy; Spain; Germany; Japan; China; India; Australia; South Korea; Brazil; Argentina; Mexico; South Africa; Saudi Arabia; Turkey
Key companies profiled
BD; Teleflex Medical; B. Braun; AngioDynamics; Smith’s Medical (ICU Medical, Inc); Medtronic; Medical Components, Inc.; Cook Medical; Terumo Medical Corporation; Access Vascular, Inc.
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global vascular access devices market report based on product, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Short Peripheral Intravenous Catheter (Short PIVCs) *
Huber Needles *
Midline Catheters *
Peripherally Inserted Central Catheter (PICCs) *
Central Venous Catheter (CVCs) *
Dialysis Catheters *
Implantable Ports *
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Ambulatory care centers
Other end-use (Clinics, etc.)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
Middle East & Africa
b. The global vascular access devices market size was estimated at USD 1.77 billion in 2022 and is expected to reach USD 1.88 billion in 2023.
b. The global vascular access devices market is expected to grow at a compound annual growth rate of 5% from 2023 to 2030 to reach USD 2.65 billion by 2030.
b. North America dominated the vascular access devices market with a share of over 58% in 2022. This is attributed to the presence of advanced healthcare infrastructure and the rising prevalence of chronic diseases in the region.
b. Some key players operating in the vascular access devices market include BD, Teleflex Medical, B. Braun, AngioDynamics, Smiths Medical (ICU Medical, Inc), Medtronic, Medical Components, Inc., Cook Medical, Terumo Medical Corporation, and Access Vascular, Inc.
b. Key factors driving the market growth include increasing demand for minimally invasive procedures, growing prevalence of chronic diseases, and technological advancements.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."